500 related articles for article (PubMed ID: 8874626)
1. Anti-herpesvirus treatment and risk of Kaposi's sarcoma in HIV infection. Royal Free/Chelsea and Westminster Hospitals Collaborative Group.
Mocroft A; Youle M; Gazzard B; Morcinek J; Halai R; Phillips AN
AIDS; 1996 Sep; 10(10):1101-5. PubMed ID: 8874626
[TBL] [Abstract][Full Text] [Related]
2. Kaposi's-sarcoma-associated herpesvirus is detected in peripheral blood mononuclear cells of HIV-infected homosexuals more often than in heterosexuals.
Rizzieri DA; Liu J; Miralles D; Traweek ST
Cancer J Sci Am; 1997; 3(3):153-6. PubMed ID: 9161780
[TBL] [Abstract][Full Text] [Related]
3. Differential impact of combination antiretroviral therapy in preventing Kaposi's sarcoma with and without visceral involvement.
Grabar S; Abraham B; Mahamat A; Del Giudice P; Rosenthal E; Costagliola D
J Clin Oncol; 2006 Jul; 24(21):3408-14. PubMed ID: 16849755
[TBL] [Abstract][Full Text] [Related]
4. Risk factors for Kaposi's sarcoma in patients with advanced human immunodeficiency virus disease treated with zidovudine. Zidovudine Epidemiology Study Group.
Gallant JE; Moore RD; Richman DD; Keruly J; Chaisson RE
Arch Intern Med; 1994 Mar; 154(5):566-72. PubMed ID: 8122950
[TBL] [Abstract][Full Text] [Related]
5. Kaposi's sarcoma: possible Foscarnet treatment?
James JS
AIDS Treat News; 1995 Jan; (No 215):4-5. PubMed ID: 11362215
[TBL] [Abstract][Full Text] [Related]
6. The effect of HAART in 254 consecutive patients with AIDS-related Kaposi's sarcoma.
Bower M; Weir J; Francis N; Newsom-Davis T; Powles S; Crook T; Boffito M; Gazzard B; Nelson M
AIDS; 2009 Aug; 23(13):1701-6. PubMed ID: 19550283
[TBL] [Abstract][Full Text] [Related]
7. Monitoring of endogenous interferon-alpha and human herpesvirus 8 in HIV-infected patients with Kaposi's sarcoma.
Plettenberg A; Albrecht D; Lorenzen T; Meyer T; Arndt R; Stoehr A
Eur J Med Res; 2002 Jan; 7(1):19-24. PubMed ID: 11827836
[TBL] [Abstract][Full Text] [Related]
8. What's new in Kaposi's sarcoma research.
Trethewey P
STEP Perspect; 1997; 9(3):9-10. PubMed ID: 11364938
[TBL] [Abstract][Full Text] [Related]
9. Influence of foscarnet on HIV-associated Kaposi's sarcoma derived cell lines.
Willers CP; Reimann G; Mertins L; Brockmeyer NH
Eur J Med Res; 1999 Dec; 4(12):514-6. PubMed ID: 10611055
[TBL] [Abstract][Full Text] [Related]
10. Seroreactivity to Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) latent nuclear antigen in AIDS-associated Kaposi's sarcoma patients depends on CD4+ T-cell count.
de Souza VA; Pierrotti LC; Sumita LM; Freire WS; Segurado AA; Pannuti CS
J Med Virol; 2007 Oct; 79(10):1562-8. PubMed ID: 17705173
[TBL] [Abstract][Full Text] [Related]
11. Use of antiherpes drugs and the risk of Kaposi's sarcoma: data from the Multicenter AIDS Cohort Study.
Glesby MJ; Hoover DR; Weng S; Graham NM; Phair JP; Detels R; Ho M; Saah AJ
J Infect Dis; 1996 Jun; 173(6):1477-80. PubMed ID: 8648224
[TBL] [Abstract][Full Text] [Related]
12. [AIDS-associated Kaposi's sarcoma: 22 cases].
Dhrif AS; Kilani B; Ammari L; Kanoun F; Tiouri H; Ben Chaaben T
Tunis Med; 2007 Jun; 85(6):494-9. PubMed ID: 17644904
[TBL] [Abstract][Full Text] [Related]
13. Effect of multiple herpesvirus infections on the progression of HIV disease in a cohort of HIV seroconverters.
Suligoi B; Dorrucci M; Uccella I; Andreoni M; Rezza G;
J Med Virol; 2003 Feb; 69(2):182-7. PubMed ID: 12683405
[TBL] [Abstract][Full Text] [Related]
14. Can antiviral agents decrease the occurrence of Kaposi's sarcoma? Clinical Epidemiology Group from Centres d'Information et de Soins de l'Immunodéficience Humaine.
Costagliola D; Mary-Krause M
Lancet; 1995 Aug; 346(8974):578. PubMed ID: 7658802
[No Abstract] [Full Text] [Related]
15. The changing pattern of AIDS-defining illnesses with the introduction of highly active antiretroviral therapy (HAART)in a London clinic.
Ives NJ; Gazzard BG; Easterbrook PJ
J Infect; 2001 Feb; 42(2):134-9. PubMed ID: 11531320
[TBL] [Abstract][Full Text] [Related]
16. Kaposi's sarcoma in HIV-negative men having sex with men.
Lanternier F; Lebbé C; Schartz N; Farhi D; Marcelin AG; Kérob D; Agbalika F; Vérola O; Gorin I; Janier M; Avril MF; Dupin N
AIDS; 2008 Jun; 22(10):1163-8. PubMed ID: 18525262
[TBL] [Abstract][Full Text] [Related]
17. [Diagnosis and treatment of HIV-related Kaposi's sarcoma].
Reyners AK; Sprenger HG; Suurmeijer AJ; van der Graaf WT
Ned Tijdschr Geneeskd; 2006 Mar; 150(11):589-93. PubMed ID: 16610494
[TBL] [Abstract][Full Text] [Related]
18. Herpesvirus treatment for KS.
Treat Rev; 1995 Nov; (no 20):5. PubMed ID: 11363024
[TBL] [Abstract][Full Text] [Related]
19. Kaposi's sarcoma-associated herpesvirus-specific immune reconstitution and antiviral effect of combined HAART/chemotherapy in HIV clade C-infected individuals with Kaposi's sarcoma.
Bihl F; Mosam A; Henry LN; Chisholm JV; Dollard S; Gumbi P; Cassol E; Page T; Mueller N; Kiepiela P; Martin JN; Coovadia HM; Scadden DT; Brander C
AIDS; 2007 Jun; 21(10):1245-52. PubMed ID: 17545700
[TBL] [Abstract][Full Text] [Related]
20. Immunological and inflammatory features of Kaposi's sarcoma and other Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8-associated neoplasias.
Riva G; Barozzi P; Torelli G; Luppi M
AIDS Rev; 2010; 12(1):40-51. PubMed ID: 20216909
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
